New hope for kids with rare metabolic disease
NCT ID NCT07163364
Summary
This study is testing an injection called hydroxocobalamin to see if it can safely control a rare, inherited disorder in children. The disorder causes harmful chemicals to build up in the body. Researchers will measure if the treatment can bring these chemical levels back to normal and help with growth and development.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHYLMALONIC ACIDEMIA (MMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.